Microrna profiling analysis of differences between the melanoma of young adults and older adults

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Jukic, Drazen M ^a   Rao, Uma N M ^a   Kelly, Lori ^a   Skaf, Jihad S ^b   Drogowski, Laura M ^a   Kirkwood, John M ^c   Panelli, Monica C ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Life Technologies   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MYELOID DIFFERENTIATION FACTOR 88; RAS PROTEIN; TOLL LIKE RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINESIS; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE; MALE; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA ANALYSIS; RNA FINGERPRINTING; RNA ISOLATION; SCHOOL CHILD; SKIN CARCINOGENESIS; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; YOUNG ADULT;

EID: 77952966659     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-27     Document Type: Article

References (79)

1. Bleyer A, OlM, Barr R, Ries LAG. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival:1975-2000. Bethesda, MD: NIH Pub No 06-5767
2. Bleyer A, Viny A, Barr R. Cancer in 15- to 29-year-olds by primary site. The Oncologist 2006, 11(6):590-601. 10.1634/theoncologist.11-6-590, 16794238.
3. Bleyer WA. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol 2002, 38(1):1-10. 10.1002/mpo.1257, 11835231.
4. Pappo AS. Melanoma in children and adolescents. Eur J Cancer 2003, 39(18):2651-2661. 10.1016/j.ejca.2003.06.001, 14642927.
5. Lange JR, Palis BE, Chang DC, Soong S-J, Balch CM. Melanoma in Children and Teenagers: An Analysis of Patients From the National Cancer Data Base. J Clin Oncol 2007, 25(11):1363-1368. 10.1200/JCO.2006.08.8310, 17416855.
6. Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 2005, 23(21):4735-4741. 10.1200/JCO.2005.02.899, 16034049.
7. Spitz S. Melanomas of childhood. 1948. CA Cancer J Clin 1991, 41(1):40-51. 10.3322/canjclin.41.1.40, 1898635.
8. Kayton ML, La Quaglia MP. Sentinel node biopsy for melanocytic tumors in children. Semin Diagn Pathol 2008, 25(2):95-9. 10.1053/j.semdp.2008.05.001, 18697712.
9. Murali R, Sharma RN, Thompson JF, Stretch JR, Lee CS, McCarthy SW, Scolyer RA. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Annals of Surgical Oncology 2008, 15(1):302-309. 10.1245/s10434-007-9577-3, 18000712.
10. Gerami P, Wass A, Mafee M, Fang Y, Pulitzer MP, Busam KJ. Fluorescence in Situ Hybridization for Distinguishing Nevoid Melanomas From Mitotically Active Nevi. Am J Surg Pathol 2009, 33(12):1783-8. 10.1097/PAS.0b013e3181ba6db6, 19809275.
11. Kirkwood JM, Jukic DM, Averbook BJ, Sender LS. Melanoma in pediatric, adolescent, and young adult patients. Semin Oncol 2009, 36(5):419-431. 10.1053/j.seminoncol.2009.07.001, 19835737.
12. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 2005, 353(17):1768-1771. 10.1056/NEJMp058190, 16251533.
13. Deng S, GA C, Croce CM, Coukos G, Zhang L. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008, 7(17):2643-2646.
14. Bartels CL, Tsongalis GJ. MicroRNAs Novel Biomarkers for Human Cancer. Clin Chem 2009, 55(4):623-631. 10.1373/clinchem.2008.112805, 19246618.
15. Mueller DW, Rehli M, Bosserhoff AK. miRNA: Expression Profiling in Melanocytes and Melanoma Cell Lines Reveals miRNAs Associated with Formation and Progression of Malignant Melanoma. J Invest Dermatol 2009, 129(7):1740-1751. 10.1038/jid.2008.452, 19212343.
16. Lewis BP, Burge CB, Bartel DP. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets. Cell 2005, 120(1):15-20. 10.1016/j.cell.2004.12.035, 15652477.
17. Wang Y, Lee ATC, Ma JZI, Wang J, Ren J, Yang Y, Tantoso E, Li KB, Ooi LLPJ, Tan P, Lee CGL. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. The Journal of biological chemistry 2008, 283:13205-13215. 10.1074/jbc.M707629200, 18319255.
18. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, Bützow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, Coukos G. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 2008, 105(19):7004-7009. 10.1073/pnas.0801615105, 2383982, 18458333.
19. Calin GA, Croce CM. MicroRNA Signatures in human cancer. Nat Rev Cancer 2006, 6:857-866. 10.1038/nrc1997, 17060945.
20. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs -- the micro steering wheel of tumour metastases. Nature Reviews Cancer 2009, 9:293-301. 10.1038/nrc2619, 19262572.
21. Simon R, Lam A. BRB-ArrayTools User Guide, version 3.2. Biometric Research Branch, National Cancer Institute., http://linus.nci.nih.gov/brb
22. Simon R, Korn E, McShane L, Radmacher M, Wright G, Zhao Y. Design and Analysis of DNA Microarray Investigations. 2003, Springer-Verlag New York.
23. Korn EL, Troendle JF, McShane LM, Simon R. Controlling the number of false discoveries: Application to high-dimensional genomic data. Journal of Statistical Planning and Inference 2004, 124:379-398.
24. Wright GW, Simon R. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003, 19:2448-2455. 10.1093/bioinformatics/btg345, 14668230.
25. Radmacher MD, McShane LM, Simon R. A paradigm for class prediction using gene expression profiles. Journal of Computational Biology 2002, 9:505-511. 10.1089/106652702760138592, 12162889.
26. Dudoit S, Fridlyand F, Speed TP. Comparison of discrimination methods for classification of tumors using DNA microarrays. Journal of the American Statistical Association 2002, 97:77-87.
27. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES, Golub TR. Multiclass cancer diagnosis using tumor gene-expression signatures. Proc Nat Acad Sci USA 2001, 98:15149-15154. 10.1073/pnas.211566398, 64998, 11742071.
28. Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the analysis of DNA microarray data: Class prediction methods. Journal of the National Cancer Institute 2003, 95:14-18.
29. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95(25):14863-14868. 10.1073/pnas.95.25.14863, 24541, 9843981.
30. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-D158. 10.1093/nar/gkm952, 2238936, 17991681.
31. Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X, Li M, Wang G, Liu Y. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 2009, 37:D98-104. 10.1093/nar/gkn714, 2686559, 18927107.
32. Igoucheva O, Alexeev V. MicroRNA-dependent regulation of cKit in cutaneous melanoma. Biochem Biophys Res Commun 2009, 379(3):790-794. 10.1016/j.bbrc.2008.12.152, 19126397.
33. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, Osman I, Hernando E. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci USA 2009, 106(6):1814-1819. 10.1073/pnas.0808263106, 2634798,2634798, 19188590.
34. Migliore C, Petrelli A, Ghiso E, Corso S, Capparuccia L, Eramo A, Comoglio PM, Giordano S. MicroRNAs impair MET-mediated invasive growth. Cancer Res 2008, 68(24):10128-10136. 10.1158/0008-5472.CAN-08-2148, 19074879.
35. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage independent growth. Cell Research 2008, 18:549-557. 10.1038/cr.2008.45, 18379589.
36. Worley LA, Long MD, Onken MD, Harbour JW. Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res 2008, 18(3):184-190. 10.1097/CMR.0b013e3282feeac6, 18477892.
37. Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, Lu F, Tu L, Qu J. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 2009, 50(4):1559-1565. 10.1167/iovs.08-2681, 19029026.
38. Glud M, Klausen M, Gniadecki R, Rossing M, Hastrup N, Nielsen FC, Drzewiecki KT. MicroRNA Expression in Melanocytic Nevi: The Usefulness of Formalin-Fixed, Paraffin-Embedded Material for miRNA Microarray Profiling. J Invest Dermato 2009, 129(5):1219-1224.
39. Barnhill RL, Argenyi ZB, From L, Glass LF, Maize JC, Mihm MC, Rabkin MS, Ronan SG, White WL, Piepkorn M. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999, 30(5):513-520. 10.1016/S0046-8177(99)90193-4, 10333219.
40. Barnhill RL, Flotte TJ, Fleischli M, Perez-Atayde A. Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer 1995, 76(10):1833-1845. 10.1002/1097-0142(19951115)76:10<1833::AID-CNCR2820761024>3.0.CO;2-L, 8625056.
41. Mones JM, Ackerman AB. "Atypical" Spitz's nevus, "malignant" Spitz's nevus, and "metastasizing" Spitz's nevus: a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol 2004, 26(4):310-333. 10.1097/00000372-200408000-00008, 15249862.
42. Busam KJ, Murali R, Pulitzer M, McCarthy SW, Thompson JF, Shaw HM, Brady MS, Coit DG, Dusza S, Wilmott J, Kayton M, Laquaglia M, Scolyer RA. Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas. Am J Surg Pathol 2009, 33(9):1386-1395. 10.1097/PAS.0b013e3181ac1927, 19609204.
43. Barnhill RL. The spitzoid lesion: the importance of atypical variants and risk assessment. Am J Dermatopathol 2006, 28(1):75-83. 10.1097/01.dad.0000188868.19869.3b, 16456332.
44. Deo M, Yu JY, Chung KH, Tippens M, Turner DL. Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev Dyn 2007, 235(9):2538-48. Erratum in: Dev Dyn 236(3):912.
45. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, Croce CM. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006, 24(29):4677-4684. 10.1200/JCO.2005.05.5194, 16966691.
46. Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG, Schnittger S, Haferlach T, Liso A, Diverio D, Mancini M, Meloni G, Foa R, Martelli MF, Mecucci C, Croce CM, Falini B. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008, 105(10):3945-3950. 10.1073/pnas.0800135105, 2268779, 18308931.
47. Wu W, Lin Z, Zhuang Z, Liang X. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev 2009, 18(1):50-55. 10.1097/CEJ.0b013e328305a07a, 19077565.
48. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006, 103(24):9136-9141. 10.1073/pnas.0508889103, 1474008,1474008, 16754881.
49. Okamoto I, Pirker C, Bilban M, Berger W, Losert D, Marosi C, Haas OA, Wolff K, Pehamberger H. Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma. Neoplasia 2005, 7(4):303-311. 10.1593/neo.04514, 1501156, 15967107.
50. Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T, Mor G. Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 2008, 27(34):4712-4723. 10.1038/onc.2008.112, 18408758.
51. Yang J, Richmond A. Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells. Cancer Res 2001, 61(12):4901-4909.
52. Livestro DP, Kaine EM, Michaelson JS, Mihm MC, Haluska FG, Muzikansky A, Sober AJ, Tanabe KK. Melanoma in the young: Differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer 2007, 110(3):614-624. 10.1002/cncr.22818, 17577228.
53. Sondak VK, Taylor JM, Sabel MS, Wang Y, Lowe L, Grover AC, Chang AE, Yahanda AM, Moon J, Johnson TM. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004, 11(3):247-258. 10.1245/ASO.2004.03.044, 14993019.
54. Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, Lee MY, Choung S, Kim YJ, Choi YC. MicroRNA miR-199a Regulates the MET Proto-oncogene and the Downstream Extracellular Signal-regulated Kinase 2 (ERK2). J Biol Chem 2008, 283(26):18158-18166. 10.1074/jbc.M800186200, 18456660.
55. Hussein K, von Neuhoff N, Büsche G, Buhr T, Kreipe H, Bock O. Opposite expression pattern of Src kinase Lyn in acute and chronic haematological malignancies. Ann Hematol 88(11):1059-1067. 10.1007/s00277-009-0727-5, 19290526.
56. Palmieri A, Pezzetti F, Spinelli G, Arlotti M, Avantaggiato A, Scarano A, Scapoli L, Zollino I, Carinci F. PerioGlas regulates osteoblast RNA interfering. J Prosthodont 2008, 17(7):522-526. 10.1111/j.1532-849X.2008.00331.x, 18573151.
57. Lee YS, Dutta A. The tumor suppressor microRNA let.-7 represses the HMGA2 oncogene. Genes Dev 2007, 21(9):1025-1030. 10.1101/gad.1540407, 1855228, 17437991.
58. Watanabe S, Ueda Y, Akaboshi S, Hino Y, Sekita Y, Nakao M. HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells. Am J Pathol 2009, 174(3):854-868. 10.2353/ajpath.2009.080523, 2665746, 19179606.
59. Schoolmeesters A, Eklund T, Leake D, Vermeulen A, Smith Q, Force Aldred S, Fedorov Y. Functional Profiling Reveals Critical Role for miRNA in Differentiation of Human Mesenchymal Stem Cells. PLoS ONE 4(5):e5605. 10.1371/journal.pone.0005605, 2680014, 19440384.
60. Prueitt RL, Yi M, Hudson RS, Wallace TA, Howe TM, Yfantis HG, Lee DH, Stephens RM, Liu CG, Calin GA, Croce CM, Ambs S. Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 2008, 68(11):1152-1164. 10.1002/pros.20786, 2597330, 18459106.
61. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297(17):1901-1908. 10.1001/jama.297.17.1901, 17473300.
62. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih I, Zhang Y, Wood W, Becker KG, Morin PJ. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 2008, 3(6):e2436. 10.1371/journal.pone.0002436, 2410296, 18560586.
63. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005, 334(4):1351-1358. 10.1016/j.bbrc.2005.07.030, 16039986.
64. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449(7163):682-688. 10.1038/nature06174, 17898713.
65. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004, 101(32):11755-11760. 10.1073/pnas.0404432101, 511048, 15284443.
66. Hutchison N, Hendry BM, Sharpe CC. Rho isoforms have distinct and specific functions in the process of epithelial to mesenchymal transition in renal proximal tubular cells. Cell Signal 2009, 21(10):1522-1531. 10.1016/j.cellsig.2009.05.012, 19477269.
67. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008, 47(3):897-907. 10.1002/hep.22160, 18176954.
68. Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Neste E, Michaux L, Heimann P, Martiat P, Bron D, Lagneaux L. MicroRNA-29c and microRNA-223 downregulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009, 113:5237-5245. 10.1182/blood-2008-11-189407, 19144983.
69. Srikumar S, Johan A, den B, I-How C, Michael A, Newton, Stephen A, Stanhope, Yu-Juen C, Chien-Jen C, Allan H, Bill S, Paul A. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA 2008, 105(15):5874-5878. 10.1073/pnas.0801130105, 2311339, 18390668.
70. Sharma VK, Ding R, Hummel A, Snopkowski C, Dadhania D, Seshan SV, Suthanthiran M, Anglicheau D. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 2009, 106(13):5330-5335. 10.1073/pnas.0800599106, 2663998, 19289845.
71. Panelli MC, Wang E, Phan G, Puhlmann M, Miller L, Ohnmacht GA, Klein HG, Marincola FM. Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration. Genome Biol 2002, 3(7):RESEARCH0035. 10.1186/gb-2002-3-7-research0035, 126240, 12184809.
72. Tzur G, Levy A, Meiri E, Barad O, Spector Y, Bentwich Z, Mizrahi L, Katzenellenbogen M, Etti Ben-Shushan E, Reubinoff BE, Galun E. MicroRNA Expression Patterns and Function in Endodermal Differentiation of Human Embryonic Stem Cells. PLoS ONE 2008, 3(11):e3726. 10.1371/journal.pone.0003726, 2581805, 19015728.
73. Chang KW, Liu CJ, Chu TH, Cheng HW, Hung PS, Hu WY, Lin SC. Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. J Dent Res 2008, 87(11):1063-1068. 10.1177/154405910808701116, 18946016.
74. Walden TB, Timmons JA, Keller P, Nedergaard J, Cannon B. Distinct expression of muscle-specific microRNAs (myomirs) in brown adipocytes. J Cell Physiol 2009, 218(2):444-449. 10.1002/jcp.21621, 18937285.
75. Lal A, Pan Y, Navarro F, Dykxhoorn DM, Moreau L, Meire E, Bentwich Z, Lieberman J, Chowdhury D. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol 2009, 16(5):492-498. 10.1038/nsmb.1589, 19377482.
76. Lui WO, Pourmand N, Patterson BK, Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 2007, 67(13):6031-6043. 10.1158/0008-5472.CAN-06-0561, 17616659.
77. De Siervi A, De Luca P, Moiola C, Gueron G, Tongbai R, Chandramouli GV, Haggerty C, Dzekunova I, Petersen D, Kawasaki E, Kil WJ, Camphausen K, Longo D, Gardner K. Identification of new Rel/NFkappaB regulatory networks by focused genome location analysis. Cell Cycle 2009, 8(13):2093-20100. 2809250, 19502793.
78. Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, Giardina C, Dahiya R. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 2009, 28(14):1714-1724. 10.1038/onc.2009.19, 19252524.
79. Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC. Determinants of BRAF Mutations in Primary Melanomas. JNCI Journal of the National Cancer Institute 2003, 95(24):1878-1890.